Answers are grounded in this paper and cite their sources.
Case report shows mepolizumab reduces hypereosinophilia in a child with TYK2 deficiency, suggesting IL-5 blockade benefits.
We report the case of a patient with complete TYK2 deficiency and virally induced hypereosinophilia and respiratory failure who responded to IL-5 blockade. TYK2 may be involved in regulating the Th1/Th2 balance in favor of Th1 and downregulating eosinophil recruitment in the airway.
No takes yet. Share an insight, caveat, or question.
Alimi et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: